产品供应(1aR,5S,8S,10R,22aR)-5-(叔丁基) -1,1a,3,4,5,6,9,10,18, 19,20,21,22,22a-十四氢-14-甲氧基-3,6-二氧代-8H- 7, 10-甲桥环

  • 发布日期:2021-06-23
  • 有效期限:30天
上海博志研新药物技术有限公司 VIP

详细信息
  • ;(1AR,5S,8S,10R,22AR)-5-(叔丁基)-1,1A,3,4,5,6,9,10,18,19,20,21,22,22A-十四氢-14-甲氧基-3,6-二氧代-8H-7,10-甲桥环丙烯并[18,19][1,10,3,6]二氧杂二氮杂环十九碳九烯并[11,12-B]喹喔啉-8-羧酸甲酯;
  • 8H-7,10-Methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid, 5-(1,1-diMethylethyl)-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-Methoxy-3,6-dioxo-, Methyl ester, (1aR,5S,8S,10R,22aR)-
  • Methyl (1aR,5S,8S,10R,22aR)-5-tert-butyl-14-methoxy-3,6-dioxo-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylate;Methyl (1aR,5S,8S,10R,22aR)-5-tert-butyl-14-methoxy-3,6-dioxo-;(1aR,5S,8S,10R,22aR)-5-(1,1-Dimethylethyl)-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid methyl ester;MK-5172 Intermediate 1; methyl(33R,35S,91R,92R,5S)-5-(tert-butyl)-17-methoxy-4,7-dioxo-2,8-dioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopropanacyclotetradecaphane-35-carboxylate;8H-7,10-Methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid, 5-(1,1-diMethylethyl)-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-Methoxy-3,6-dioxo-, Methyl ester, (1aR,5S,8S,10R,22aR)-;
  • CAS NO:1206524-84-6

免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,化工网对此不承担任何保证责任。我们原则上建议您选择化工网高级会员或VIP会员。